FACET ECZEMA Research Study

The purpose of this study is to assess the use of the telemedicine platform, Facet, for determining patient satisfaction with inclusion of adjunctive therapy during the care of eczema. 

The study is approximately 4 weeks long and is fully remote. During this time, you will use the study product, have weekly follow-up surveys and check-ins with the study team. 

You will be compensated up to $150 in the form of an electronic gift card.

Click here to take part
Haga clic aquí para participar
Klik hier om deel te nemen

Study for

Estudio dirigido a

Zielgrupper der Studie

Onderzoek voor:

Men and Women aged 18 to 64 with mild to moderate eczema and who are currently using the Facet platform

Sponsored by

Patrocinado por

Gesponsert von


Thirty Madison & Johnson and Johnson (JnJ)








Participate by

Participar mediante


Duur van onderzoek:

September 30, 2023




What is expected of me? 

¿Qué se espera de mí?

Was wird von mir erwartet?

Wat wordt van mij verwacht?

  1. First you will fill out a pre-screening questionnaire on this website to see if you are eligible to participate.
  2. If you are eligible, you will have a call with the study team to review the study and informed consent form.  
  3. If you decide to participate, the study team will determine your eligibility and ship you body wash and body cream to use daily and additionally as desired. 
  4. You will be followed for 4 weeks completing online questionnaires weekly.
  5. You will take photos of your target Eczema lesion (active area of eczema) at the start & end of the study.   
  6. You will attend all your standard Eczema appointments and continue all prescribed Eczema treatments.

What is the benefit for me?

¿En qué me beneficia?

Welchen Nutzen habe ich davon?

Wat is het voordeel voor mij?

  • You can earn up to $150 for full participation. Compensation will be in the form of an electronic gift card. 
  • Participating in this study will give you the opportunity to help further Eczema research

Who is the study for? 

¿A quién va dirigido el estudio?

Für wen ist die Studie geeignet?

Voor wie is het onderzoek bedoeld?


  • Aged 18 to 64 years
  • Diagnosed with Mild/Moderate Eczema 
  • Currently using the Facet Platform

Complete this questionnaire to take part.

Fülle diesen Fragebogen aus, um herauszufinden, ob Du berechtigt bist